Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 21, 2024
Visible Light Promoted Site-Specific Functionalization of α-Acyloxy Carboxamides: Unlocking a Forbidden Chemical Space in the Passerini ReactionFrancesca Brunelli, Francesca Quartieri, Ivana Miletto, et al.
Journal of the American Chemical Society|September 22, 2005
Sensitivity improvement in 19F NMR-based screening experiments: theoretical considerations and experimental applicationsClaudio Dalvit, Nicola Mongelli, Gianluca Papeo, et al.
Expert Opinion on Therapeutic Patents|September 12, 2009
Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?Gianluca Papeo, Barbara Forte, Paolo Orsini, et al.
The Journal of Organic Chemistry|July 5, 2025
Sustainable Photocatalytic Synthesis of Glitazones via Riboflavin TetraacetateSarah Jane Rezzi, Marco Koten, Rita Maria Concetta Di Martino, et al.
Journal of the American Chemical Society|April 10, 2007
Polyfluorinated amino acids for sensitive 19F NMR-based screening and kinetic measurementsGianluca Papeo, Patrizia Giordano, Maria Gabriella Brasca, et al.
Journal of Biomolecular Screening|June 12, 2014
Insights into PARP Inhibitors' Selectivity Using Fluorescence Polarization and Surface Plasmon Resonance Binding AssaysGianluca Papeo, Nilla Avanzi, Serena Bettoni, et al.
Chirality|August 12, 2022
Stereoselective synthesis of 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as PIM kinase inhibitors inspired from marine alkaloidsFrancesco Casuscelli, Elena Ardini, Nilla Avanzi, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Discovery of Stereospecific PARP-1 Inhibitor Isoindolinone NMS-P515Gianluca Papeo, Paolo Orsini, Nilla R Avanzi, et al.
Bioorganic & Medicinal Chemistry|October 22, 2013
Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinasesFrancesco Casuscelli, Elena Ardini, Nilla Avanzi, et al.
Journal of Medicinal Chemistry|July 30, 2015
Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer TherapyGianluca Papeo, Helena Posteri, Daniela Borghi, et al.
Pageof 2